FDA approves Datroway for HR-positive, HER2-negative breast most cancers
The U.S. Meals and Drug Administration has authorized Datroway (datopotamab deruxtecan-dlnk) for…
Search
The U.S. Meals and Drug Administration has authorized Datroway (datopotamab deruxtecan-dlnk) for…
